NASDAQ:CRON

Cronos Group - CRON Stock Forecast, Price & News

$2.49

-0.09 (-3.49%)

(As of 02/3/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.49
▼
$2.57
50-Day Range: $2.42
▼
$3.50
52-Week Range: $2.39
▼
$4.31

Volume: 1.53 million shs
Average Volume: 1.53 million shs
Market Capitalization: $947.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.21

Institutional Ownership

Cronos Group MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.57 Rating Score
Upside/Downside: 69.2% Upside
$4.21 Price Target
Short Interest: Bearish
3.98% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.48
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$1.30 M Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.29) to ($0.19) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.87 out of 5 stars

Medical Sector

694th out of 1,029 stocks

Medicinals & Botanicals Industry

9th out of 15 stocks

3.3

Analyst's Opinion

Consensus Rating
Cronos Group has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $4.21, Cronos Group has a forecasted upside of 69.2% from its current price of $2.49.
Amount of Analyst Coverage
Cronos Group has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
3.98% of the float of Cronos Group has been sold short.
Short Interest Ratio / Days to Cover
Cronos Group has a short interest ratio ("days to cover") of 4.5.
Change versus previous month
Short interest in Cronos Group has recently increased by 0.13%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Cronos Group does not currently pay a dividend.
Dividend Growth
Cronos Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CRON.

0.8

News and Social Media Coverage

News Sentiment
Cronos Group has a news sentiment score of -0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Cronos Group this week, compared to 2 articles on an average week.
Search Interest
Only 4 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,302,605.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 5.95% of the stock of Cronos Group is held by insiders.
Percentage Held by Institutions
Only 11.94% of the stock of Cronos Group is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Cronos Group are expected to grow in the coming year, from ($0.29) to ($0.19) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cronos Group has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Cronos Group (NASDAQ:CRON) Stock

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

January 30, 2023 | msn.com

Altria Group Stock: Bull vs. Bear

January 29, 2023 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Materials Companies: Archer Daniels Midland (ADM) and Cronos Group (CRON)

February 3, 2023 | Investor Place Media (Ad)

Cash Holders STILL Aren't Taking Steps to Prepare

Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.

January 27, 2023 | americanbankingnews.com

Cronos Group (NASDAQ:CRON) Sets New 52-Week Low at $2.39

January 25, 2023 | marketwatch.com

Cronos Group Inc. stock remains steady Wednesday, still outperforms market

January 25, 2023 | americanbankingnews.com

Cronos Group Inc. (NASDAQ:CRON) Sees Significant Increase in Short Interest

January 22, 2023 | morningstar.com

Cronos Group Inc CRON Stock Quote

January 19, 2023 | msn.com

'Youth Oriented' Labels, Lack Of Regulation To Blame For Child Marijuana Poisonings

February 3, 2023 | Tradewins (Ad)

Know Your Profit Potential BEFORE You Trade!

I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now!

January 17, 2023 | marketwatch.com

Legalized Canabis Market Size 2023 with Over-all Dominated, Share of Everywhere, Ease of Access of Solutions

December 26, 2022 | finance.yahoo.com

Cryptocurrencies To Watch: Week of December 26

December 19, 2022 | proactiveinvestors.com

Altria Group relinquishes warrant which could have led to increased stake in Cronos Group

December 19, 2022 | marketwatch.com

Cronos Shares Fall 4% After Altria Abandons Warrant Upping Stake

December 19, 2022 | benzinga.com

Altria Abandons Expiring Cronos Warrant, Maintains Initial Investment

December 19, 2022 | finance.yahoo.com

Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria

December 7, 2022 | benzinga.com

Cronos Launches Spinach FEELZ Day Trip Gummies With THC And CBC

December 6, 2022 | baystreet.ca

Equities Bruised Ahead of BoC Decision

November 25, 2022 | marketwatch.com

CBD-infused Cosmetics Market 2023 : Projected to Deliver Greater Revenues during the Forecast Period 2028

November 22, 2022 | finance.yahoo.com

Here's Why I'm Closing My Crypto.Com Account in 2023

November 16, 2022 | finance.yahoo.com

Why Cardano, Chainlink, and Cronos Are Slumping Today

November 14, 2022 | finance.yahoo.com

Matt Damon Crypto.com's Coin Is in Free Fall

November 14, 2022 | finance.yahoo.com

Crypto.com’s Sinking Token Stirs Fresh Anxiety After FTX Wipeout

November 14, 2022 | finance.yahoo.com

Cronos Group Appoints James Holm as Chief Financial Officer

November 14, 2022 | finance.yahoo.com

Cannabis-focused Scotts Miracle-Gro, Cronos both hire new chief financial officers

November 8, 2022 | seekingalpha.com

Cronos Group: There Are Green Shoots Amid The Weeds

November 7, 2022 | finance.yahoo.com

Cronos Group (CRON) Reports Q3 Loss, Misses Revenue Estimates

November 7, 2022 | marketwatch.com

Cronos Swings to Loss in 3Q as Revenue Growth Misses Views

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Company Calendar

Last Earnings: 11/07/2022
Today: 2/03/2023
Next Earnings (Estimated): 3/07/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medicinals & botanicals
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CRON
CUSIP: N/A
CIK: 1656472
Web: www.thecronosgroup.com
Phone: (416) 504-0004
Fax: N/A
Employees: 626
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $4.21
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +69.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.57
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.60)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-396,110,000.00
Net Margins: -235.72%
Pretax Margin: -234.01%
Return on Equity: -16.29%
Return on Assets: -15.66%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 25.37
Quick Ratio: 24.47

Sales & Book Value

Annual Sales: $74.43 million
Price / Sales: 12.73
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.56 per share
Price / Book: 0.70

Miscellaneous

Outstanding Shares: 380,480,000
Free Float: 357,838,000
Market Cap: $947.40 million
Optionable: Optionable
Beta: 1.52

Key Executives

Michael Ryan Gorenstein
Chairman, President & Chief Executive Officer

James Holm
Chief Financial Officer

Arye Weigensberg
Vice President-Research & Technology

Jeffrey Jacobson
Senior VP, Head-Growth-North America

Shannon Buggy
Senior Vice President & Global Head-People

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares.
View CRON analyst ratings or view top-rated stocks.
What is Cronos Group's stock price forecast for 2023?: 7 Wall Street analysts have issued 12 month target prices for Cronos Group's shares. Their CRON share price forecasts range from $3.00 to $7.00. On average, they predict the company's share price to reach $4.21 in the next year. This suggests a possible upside of 65.3% from the stock's current price.
View analysts price targets for CRON or view top-rated stocks among Wall Street analysts.
How have CRON shares performed in 2023?: Cronos Group's stock was trading at $2.54 on January 1st, 2023. Since then, CRON shares have increased by 0.4% and is now trading at $2.55.
View the best growth stocks for 2023 here.
When is Cronos Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our CRON earnings forecast.
How were Cronos Group's earnings last quarter?: Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Monday, November, 7th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The business earned $20.92 million during the quarter, compared to analysts' expectations of $23.30 million. Cronos Group had a negative net margin of 235.72% and a negative trailing twelve-month return on equity of 16.29%.
What other stocks do shareholders of Cronos Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI).

What is Cronos Group's stock symbol?: Cronos Group trades on the NASDAQ under the ticker symbol "CRON."
Who are Cronos Group's major shareholders?: Cronos Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Simplex Trading LLC (0.00%), Janney Montgomery Scott LLC (0.06%), National Bank of Canada FI (0.03%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%), Bank of Montreal Can (0.00%) and Johnson & White Wealth Management LLC (0.00%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends.
How do I buy shares of Cronos Group?: Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cronos Group's stock price today?: One share of CRON stock can currently be purchased for approximately $2.55.
How much money does Cronos Group make?: Cronos Group (NASDAQ:CRON) has a market capitalization of $970.22 million and generates $74.43 million in revenue each year. The company earns $-396,110,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.
How many employees does Cronos Group have?: The company employs 626 workers across the globe.
How can I contact Cronos Group?: Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.

This page (NASDAQ:CRON) was last updated on 2/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cronos Group - CRON Stock Forecast, Price & News

Cronos Group MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Cronos Group (NASDAQ:CRON) Stock

CRON Stock News Headlines

CRON Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CRON Stock - Frequently Asked Questions

Overall MarketRank^™